Close Menu

NEW YORK – Evercore ISI on Thursday upgraded PerkinElmer's shares to Outperform from a prior In Line rating, but the investment bank downgraded Hologic's stock to In Line from an Outperform rating.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.